Сокол Мария Борисовна

Институт биохимической физики им. Н.М. Эмануэля РАН

Crossref Scopus Web of science

Публикаций

Цитирований

Индекс Хирша

Лаборатория биотехнологий и наноструктур для адресной доставки лекарств

Младший научный сотрудник

По дате

По цитируемости

Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe

Yabbarov N., Nikolskaya E., Sokol M., Mollaeva M., Chirkina M., Seregina I., Gulyaev M., Pirogov Y., Petrov R.

Q1 International Journal of Molecular Sciences, 2022, цитирований: 0 ,

Open Access

Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles

Mollaeva M.R., Nikolskaya E., Beganovskaya V., Sokol M., Chirkina M., Obydennyi S., Belykh D., Startseva O., Mollaev M.D., Yabbarov N.

Q1 Antioxidants, 2021, цитирований: 3 ,

Open Access

Development of the Composition and Technology for Obtaining Paclitaxel Nanoscale Formulation Consisting of a Conjugate of Polymer Particles with a Protein Vector Molecule

Sokol M.B., Yabbarov N.G., Mollaeva M.R., Chirkina (Fomicheva) M.V., Balaban'yan V.Y., Nikolskaya E.D.

Q3 Drug development & registration, 2021, цитирований: 2

Optimization, Characterization and Pharmacokinetic Study of Meso-Tetraphenylporphyrin Metal Complex-Loaded PLGA Nanoparticles

Mollaeva M.R., Yabbarov N., Sokol M., Chirkina M., Mollaev M.D., Zabolotskii A., Seregina I., Bolshov M., Kaplun A., Nikolskaya E.

Q1 International Journal of Molecular Sciences, 2021, цитирований: 3 ,

Open Access

Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli

Mollaev M., Zabolotskii A., Gorokhovets N., Nikolskaya E., Sokol M., Tsedilin A., Mollaeva M., Chirkina M., Kuvaev T., Pshenichnikova A., Yabbarov N.

Q2 Journal of Genetic Engineering and Biotechnology, 2021, цитирований: 2 ,

Open Access

Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study

Sokol M., Zenin V., Yabbarov N., Mollaev M., Zabolotsky A., Mollaeva M., Fomicheva M., Kuznetsov S., Popenko V., Seregina I., Nikolskaya E.

Q3 Annales Pharmaceutiques Francaises, 2021, цитирований: 1

Obtaining and Purification of Recombinant Domain III of Human Alpha-Fetoprotein

Mollaev M.D., Zabolotskii A.I., Mazalev D.A., Gorokhovets N.V., Sokol M.B., Mollaeva M.R., Fomicheva M.V., Pshenichnikova A.B., Nikolskaya E.D.

Q4 Biotekhnologiya, 2021, цитирований: 2

Validation of a UV-Spectrophotometric Method for Quantitative Determination of Paclitaxel in a Targeted Delivery System Based on Poly(Lactic–Glycolic Acid) Copolymer Nanoparticles

Sokol M.B., Sycheva Y.V., Yabbarov N.G., Zabolotskii A.I., Mollaev M.D., Faustova M.R., Tereshchenko O.G., Fomicheva M.V., Nikol’skaya E.D.

Q4 Pharmaceutical Chemistry Journal, 2020, цитирований: 0

Metalloporphyrins in Medicine: From History to Recent Trends.

Faustova M., Nikolskaya E., Sokol M., Fomicheva M., Petrov R., Yabbarov N.

Q1 ACS Applied Bio Materials, 2020, цитирований: 7

Cellular internalization of targeted and non-targeted delivery systems for contrast agents based on polyamidoamine dendrimers

Sokol M.B., Faustova M.R., Nikolskaya E.D., Zhunina O.A., Fomicheva M.V., Petrov R.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2020, цитирований: 4

Polymer particles containing Fe-based metalloporphyrin as a highly efficient stimulator of reactive oxygen species formation in vitro and in vivo

Faustova M.R., Nikolskaya E.D., Mollaev M.D., Sokol M.B., Zabolotsky A.I., Zhunina O.A., Fomicheva M.V., Schvets V.I., Lobanov A.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2019, цитирований: 2

High-effective reactive oxygen species inducer based on Mn-tetraphenylporphyrin loaded PLGA nanoparticles in binary catalyst therapy

Faustova M., Nikolskaya E., Sokol M., Zabolotsky A., Mollaev M., Zhunina O., Fomicheva M., Lobanov A., Severin E., Yabbarov N.

Q1 Free Radical Biology and Medicine, 2019, цитирований: 7

Type of pH sensitive linker reveals different time-dependent intracellular localization, in vitro and in vivo efficiency in alpha-fetoprotein receptor targeted doxorubicin conjugate

Mollaev M., Gorokhovets N., Nikolskaya E., Faustova M., Zabolotsky A., Zhunina O., Sokol M., Zamulaeva I., Severin E., Yabbarov N.

Q1 International Journal of Pharmaceutics, 2019, цитирований: 13 ,

Open Access

Formulation of perspective hepatoprotector polymeric forms based on silybin and ursodeoxycholic acid

Tereshchenko O.G., Nikolskaya E.D., Zhunina O.A., Zavarzina V.V., Yabbarov N.G., Fomicheva M.V., Zubkov E.V., Sokol M.B., Gukasova N.V., Severin E.S.

Q3 Russian Chemical Bulletin, 2018, цитирований: 7

Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells

Sokol M.B., Nikolskaya E.D., Yabbarov N.G., Zenin V.A., Faustova M.R., Belov A.V., Zhunina O.A., Mollaev M.D., Zabolotsky A.I., Tereshchenko O.G., Severin E.S.

Q2 Journal of Biomedical Materials Research - Part B Applied Biomaterials, 2018, цитирований: 27

Всего публикаций

Всего цитирований

Цитирований на публикацию

4.57

Среднее число публикаций в год

3.5

Среднее число соавторов

8.29

Годы публикаций

2017-2022 (6 лет)

h-index

i10-index

m-index

o-index

g-index

w-index

Описание метрик

h-index

Учёный имеет индекс h, если h из его N статей цитируются как минимум h раз каждая, в то время как оставшиеся (N - h) статей цитируются не более чем h раз каждая.

https://www.pnas.org/doi/full/10.1073/pnas.0507655102

i10-index

Число статей автора, получивших не менее 10 ссылок каждая.

https://scholar.googleblog.com/2011/11/google-scholar-citations-open-to-all.html

m-index

m-индекс ученого численно равен отношению его h-индекса к количеству лет, прошедших с момента первой публикации.

https://harzing.com/publications/white-papers/reflections-on-the-h-index

o-index

Среднее геометрическое h-индекса и числа цитирований наиболее цитируемой статьи ученого.

https://arxiv.org/abs/1511.01545

g-index

Для данного множества статей, отсортированного в порядке убывания количества цитирований, которые получили эти статьи, g-индекс это наибольшее число, такое что g самых цитируемых статей получили (суммарно) не менее g² цитирований.

https://doi.org/10.1007/s11192-006-0144-7

w-index

Если w статей ученого имеют не менее 10w цитирований каждая и другие статьи меньше, чем 10(w+1) цитирований, то w-индекс исследователя равен w.

https://doi.org/10.1002/asi.21276

Мы не учитываем публикации, у которых нет DOI.
Публикации с конференций и главы книг не учитываются в графиках «Журналы» и «Издатели».
Статистика пересчитывается раз в сутки.

{"yearsTotal":6,"yearsFrom":2017,"yearsTo":2022,"totalCitations":96,"totalPublications":21,"averageCitations":"4.57","averagePublicationsPerYear":"3.5","averageCoAuthors":"8.29","hIndex":6,"iTenIndex":2,"mIndex":"1","oIndex":12,"gIndex":8,"wIndex":1,"journals":{"type":"bar","data":{"show":true,"labels":["Russian Chemical Bulletin","International Journal of Molecular Sciences","Pharmaceutical Chemistry Journal","Biotekhnologiya","Protein Expression and Purification","International Journal of Pharmaceutics","Annales Pharmaceutiques Francaises","Acta of Bioengineering and Biomechanics","Journal of Biomedical Materials Research - Part B Applied Biomaterials","Russian Journal of Bioorganic Chemistry","Antioxidants","Free Radical Biology and Medicine","ACS Applied Bio Materials","Journal of Genetic Engineering and Biotechnology","Drug development & registration"],"datasets":[{"label":"\u041a\u043e\u043b\u0438\u0447\u0435\u0441\u0442\u0432\u043e \u043f\u0443\u0431\u043b\u0438\u043a\u0430\u0446\u0438\u0439","data":[6,2,1,1,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[28.57,9.52,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76],"barThickness":26}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"\u0416\u0443\u0440\u043d\u0430\u043b\u044b","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"openAccess":{"type":"pie","data":{"show":true,"labels":["Open access","Closed access"],"datasets":[{"label":"\u00abOpen access\u00bb","data":[6,15],"backgroundColor":["#f68212","#E5E7EB"],"hoverOffset":4,"percentage":[28.57,71.43]}]},"options":{"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"\u00abOpen access\u00bb","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Springer Nature","Elsevier","Multidisciplinary Digital Publishing Institute (MDPI)","Wiley-Blackwell","American Chemical Society","Pleiades Publishing","State Research Institute for Genetics and Selection of Industrial Microorganisms","Oficyna Wydawnicza","Center of Pharmaceutical Analytics Ltd"],"datasets":[{"label":"\u041a\u043e\u043b\u0438\u0447\u0435\u0441\u0442\u0432\u043e \u043f\u0443\u0431\u043b\u0438\u043a\u0430\u0446\u0438\u0439","data":[8,4,3,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[38.1,19.05,14.29,4.76,4.76,4.76,4.76,4.76,4.76],"barThickness":26}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"\u0418\u0437\u0434\u0430\u0442\u0435\u043b\u0438","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"quartiles":{"type":"pie","data":{"show":true,"labels":["Q1","Q2","Q3","Q4"],"datasets":[{"label":"\u041a\u0432\u0430\u0440\u0442\u0438\u043b\u0438 \u043f\u043e SCImago","data":[6,2,10,3],"backgroundColor":["#3B82F6","#60A5FA","#93C5FD","#BFDBFE"],"hoverOffset":4,"percentage":[28.57,9.52,47.62,14.29]}]},"options":{"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"\u041a\u0432\u0430\u0440\u0442\u0438\u043b\u0438 \u043f\u043e SCImago","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"quartilesWs":{"type":"pie","data":{"show":true,"labels":["\u041a\u0432\u0430\u0440\u0442\u0438\u043b\u044c \u043e\u0442\u0441\u0443\u0442\u0441\u0442\u0432\u0443\u0435\u0442","Q1","Q2","Q3","Q4"],"datasets":[{"label":"\u041a\u0432\u0430\u0440\u0442\u0438\u043b\u0438 \u043f\u043e Web of Science","data":[5,5,0,1,10],"backgroundColor":["#E5E7EB","#3B82F6","#60A5FA","#93C5FD","#BFDBFE"],"hoverOffset":4,"percentage":[23.81,23.81,0,4.76,47.62]}]},"options":{"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"\u041a\u0432\u0430\u0440\u0442\u0438\u043b\u0438 \u043f\u043e Web of Science","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"subjects":{"type":"bar","data":{"show":true,"labels":["General Chemistry","Organic Chemistry","Biochemistry","Molecular Biology","Pharmaceutical Science","Biotechnology","Catalysis","Drug Discovery","Inorganic Chemistry","Physical and Theoretical Chemistry","Computer Science Applications","Spectroscopy","General Medicine","Pharmacology","Biomaterials","Biomedical Engineering","Cell Biology","Genetics","Clinical Biochemistry","Applied Microbiology and Biotechnology","Biochemistry, medical","Physiology","Physiology (medical)","Ecology"],"datasets":[{"label":"\u041a\u043e\u043b\u0438\u0447\u0435\u0441\u0442\u0432\u043e \u043f\u0443\u0431\u043b\u0438\u043a\u0430\u0446\u0438\u0439","data":[7,3,3,3,3,3,2,2,2,2,2,2,2,2,2,2,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[33.33,14.29,14.29,14.29,14.29,14.29,9.52,9.52,9.52,9.52,9.52,9.52,9.52,9.52,9.52,9.52,4.76,4.76,4.76,4.76,4.76,4.76,4.76,4.76],"barThickness":26}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"\u041e\u0431\u043b\u0430\u0441\u0442\u0438 \u043d\u0430\u0443\u043a","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"years":{"type":"bar","data":{"show":true,"labels":[2017,2018,2019,2020,2021,2022],"datasets":[{"label":"\u041a\u043e\u043b\u0438\u0447\u0435\u0441\u0442\u0432\u043e \u043f\u0443\u0431\u043b\u0438\u043a\u0430\u0446\u0438\u0439","data":[3,5,3,3,6,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[14.29,23.81,14.29,14.29,28.57,4.76],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"\u041f\u0443\u0431\u043b\u0438\u043a\u0430\u0446\u0438\u0439 \u0437\u0430 \u0433\u043e\u0434","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}

В этом разделе отображаются профили ученых, зарегистрированных на платформе. Чтобы отображался полный список, приглашайте коллег зарегистрироваться.

Общих публикаций: 22

По дате

По цитируемости

Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe

Yabbarov N., Nikolskaya E., Sokol M., Mollaeva M., Chirkina M., Seregina I., Gulyaev M., Pirogov Y., Petrov R.

Q1 International Journal of Molecular Sciences, 2022, цитирований: 0 ,

Open Access

Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles

Mollaeva M.R., Nikolskaya E., Beganovskaya V., Sokol M., Chirkina M., Obydennyi S., Belykh D., Startseva O., Mollaev M.D., Yabbarov N.

Q1 Antioxidants, 2021, цитирований: 3 ,

Open Access

Development of the Composition and Technology for Obtaining Paclitaxel Nanoscale Formulation Consisting of a Conjugate of Polymer Particles with a Protein Vector Molecule

Sokol M.B., Yabbarov N.G., Mollaeva M.R., Chirkina (Fomicheva) M.V., Balaban'yan V.Y., Nikolskaya E.D.

Q3 Drug development & registration, 2021, цитирований: 2

Optimization, Characterization and Pharmacokinetic Study of Meso-Tetraphenylporphyrin Metal Complex-Loaded PLGA Nanoparticles

Mollaeva M.R., Yabbarov N., Sokol M., Chirkina M., Mollaev M.D., Zabolotskii A., Seregina I., Bolshov M., Kaplun A., Nikolskaya E.

Q1 International Journal of Molecular Sciences, 2021, цитирований: 3 ,

Open Access

Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli

Mollaev M., Zabolotskii A., Gorokhovets N., Nikolskaya E., Sokol M., Tsedilin A., Mollaeva M., Chirkina M., Kuvaev T., Pshenichnikova A., Yabbarov N.

Q2 Journal of Genetic Engineering and Biotechnology, 2021, цитирований: 2 ,

Open Access

Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study

Sokol M., Zenin V., Yabbarov N., Mollaev M., Zabolotsky A., Mollaeva M., Fomicheva M., Kuznetsov S., Popenko V., Seregina I., Nikolskaya E.

Q3 Annales Pharmaceutiques Francaises, 2021, цитирований: 1

Obtaining and Purification of Recombinant Domain III of Human Alpha-Fetoprotein

Mollaev M.D., Zabolotskii A.I., Mazalev D.A., Gorokhovets N.V., Sokol M.B., Mollaeva M.R., Fomicheva M.V., Pshenichnikova A.B., Nikolskaya E.D.

Q4 Biotekhnologiya, 2021, цитирований: 2

Validation of a UV-Spectrophotometric Method for Quantitative Determination of Paclitaxel in a Targeted Delivery System Based on Poly(Lactic–Glycolic Acid) Copolymer Nanoparticles

Sokol M.B., Sycheva Y.V., Yabbarov N.G., Zabolotskii A.I., Mollaev M.D., Faustova M.R., Tereshchenko O.G., Fomicheva M.V., Nikol’skaya E.D.

Q4 Pharmaceutical Chemistry Journal, 2020, цитирований: 0

Metalloporphyrins in Medicine: From History to Recent Trends.

Faustova M., Nikolskaya E., Sokol M., Fomicheva M., Petrov R., Yabbarov N.

Q1 ACS Applied Bio Materials, 2020, цитирований: 7

Cellular internalization of targeted and non-targeted delivery systems for contrast agents based on polyamidoamine dendrimers

Sokol M.B., Faustova M.R., Nikolskaya E.D., Zhunina O.A., Fomicheva M.V., Petrov R.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2020, цитирований: 4

Polymer particles containing Fe-based metalloporphyrin as a highly efficient stimulator of reactive oxygen species formation in vitro and in vivo

Faustova M.R., Nikolskaya E.D., Mollaev M.D., Sokol M.B., Zabolotsky A.I., Zhunina O.A., Fomicheva M.V., Schvets V.I., Lobanov A.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2019, цитирований: 2

High-effective reactive oxygen species inducer based on Mn-tetraphenylporphyrin loaded PLGA nanoparticles in binary catalyst therapy

Faustova M., Nikolskaya E., Sokol M., Zabolotsky A., Mollaev M., Zhunina O., Fomicheva M., Lobanov A., Severin E., Yabbarov N.

Q1 Free Radical Biology and Medicine, 2019, цитирований: 7

Type of pH sensitive linker reveals different time-dependent intracellular localization, in vitro and in vivo efficiency in alpha-fetoprotein receptor targeted doxorubicin conjugate

Mollaev M., Gorokhovets N., Nikolskaya E., Faustova M., Zabolotsky A., Zhunina O., Sokol M., Zamulaeva I., Severin E., Yabbarov N.

Q1 International Journal of Pharmaceutics, 2019, цитирований: 13 ,

Open Access

Formulation of perspective hepatoprotector polymeric forms based on silybin and ursodeoxycholic acid

Tereshchenko O.G., Nikolskaya E.D., Zhunina O.A., Zavarzina V.V., Yabbarov N.G., Fomicheva M.V., Zubkov E.V., Sokol M.B., Gukasova N.V., Severin E.S.

Q3 Russian Chemical Bulletin, 2018, цитирований: 7

Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells

Sokol M.B., Nikolskaya E.D., Yabbarov N.G., Zenin V.A., Faustova M.R., Belov A.V., Zhunina O.A., Mollaev M.D., Zabolotsky A.I., Tereshchenko O.G., Severin E.S.

Q2 Journal of Biomedical Materials Research - Part B Applied Biomaterials, 2018, цитирований: 27

Никольская Елена

Области научных интересов

Адресная доставка лекарств

Наноматериалы

Нанотехнологии

Персонализированная медицина

Общих публикаций: 22

По дате

По цитируемости

Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe

Yabbarov N., Nikolskaya E., Sokol M., Mollaeva M., Chirkina M., Seregina I., Gulyaev M., Pirogov Y., Petrov R.

Q1 International Journal of Molecular Sciences, 2022, цитирований: 0 ,

Open Access

Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles

Mollaeva M.R., Nikolskaya E., Beganovskaya V., Sokol M., Chirkina M., Obydennyi S., Belykh D., Startseva O., Mollaev M.D., Yabbarov N.

Q1 Antioxidants, 2021, цитирований: 3 ,

Open Access

Development of the Composition and Technology for Obtaining Paclitaxel Nanoscale Formulation Consisting of a Conjugate of Polymer Particles with a Protein Vector Molecule

Sokol M.B., Yabbarov N.G., Mollaeva M.R., Chirkina (Fomicheva) M.V., Balaban'yan V.Y., Nikolskaya E.D.

Q3 Drug development & registration, 2021, цитирований: 2

Optimization, Characterization and Pharmacokinetic Study of Meso-Tetraphenylporphyrin Metal Complex-Loaded PLGA Nanoparticles

Mollaeva M.R., Yabbarov N., Sokol M., Chirkina M., Mollaev M.D., Zabolotskii A., Seregina I., Bolshov M., Kaplun A., Nikolskaya E.

Q1 International Journal of Molecular Sciences, 2021, цитирований: 3 ,

Open Access

Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli

Mollaev M., Zabolotskii A., Gorokhovets N., Nikolskaya E., Sokol M., Tsedilin A., Mollaeva M., Chirkina M., Kuvaev T., Pshenichnikova A., Yabbarov N.

Q2 Journal of Genetic Engineering and Biotechnology, 2021, цитирований: 2 ,

Open Access

Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study

Sokol M., Zenin V., Yabbarov N., Mollaev M., Zabolotsky A., Mollaeva M., Fomicheva M., Kuznetsov S., Popenko V., Seregina I., Nikolskaya E.

Q3 Annales Pharmaceutiques Francaises, 2021, цитирований: 1

Obtaining and Purification of Recombinant Domain III of Human Alpha-Fetoprotein

Mollaev M.D., Zabolotskii A.I., Mazalev D.A., Gorokhovets N.V., Sokol M.B., Mollaeva M.R., Fomicheva M.V., Pshenichnikova A.B., Nikolskaya E.D.

Q4 Biotekhnologiya, 2021, цитирований: 2

Validation of a UV-Spectrophotometric Method for Quantitative Determination of Paclitaxel in a Targeted Delivery System Based on Poly(Lactic–Glycolic Acid) Copolymer Nanoparticles

Sokol M.B., Sycheva Y.V., Yabbarov N.G., Zabolotskii A.I., Mollaev M.D., Faustova M.R., Tereshchenko O.G., Fomicheva M.V., Nikol’skaya E.D.

Q4 Pharmaceutical Chemistry Journal, 2020, цитирований: 0

Metalloporphyrins in Medicine: From History to Recent Trends.

Faustova M., Nikolskaya E., Sokol M., Fomicheva M., Petrov R., Yabbarov N.

Q1 ACS Applied Bio Materials, 2020, цитирований: 7

Cellular internalization of targeted and non-targeted delivery systems for contrast agents based on polyamidoamine dendrimers

Sokol M.B., Faustova M.R., Nikolskaya E.D., Zhunina O.A., Fomicheva M.V., Petrov R.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2020, цитирований: 4

Polymer particles containing Fe-based metalloporphyrin as a highly efficient stimulator of reactive oxygen species formation in vitro and in vivo

Faustova M.R., Nikolskaya E.D., Mollaev M.D., Sokol M.B., Zabolotsky A.I., Zhunina O.A., Fomicheva M.V., Schvets V.I., Lobanov A.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2019, цитирований: 2

High-effective reactive oxygen species inducer based on Mn-tetraphenylporphyrin loaded PLGA nanoparticles in binary catalyst therapy

Faustova M., Nikolskaya E., Sokol M., Zabolotsky A., Mollaev M., Zhunina O., Fomicheva M., Lobanov A., Severin E., Yabbarov N.

Q1 Free Radical Biology and Medicine, 2019, цитирований: 7

Type of pH sensitive linker reveals different time-dependent intracellular localization, in vitro and in vivo efficiency in alpha-fetoprotein receptor targeted doxorubicin conjugate

Mollaev M., Gorokhovets N., Nikolskaya E., Faustova M., Zabolotsky A., Zhunina O., Sokol M., Zamulaeva I., Severin E., Yabbarov N.

Q1 International Journal of Pharmaceutics, 2019, цитирований: 13 ,

Open Access

Formulation of perspective hepatoprotector polymeric forms based on silybin and ursodeoxycholic acid

Tereshchenko O.G., Nikolskaya E.D., Zhunina O.A., Zavarzina V.V., Yabbarov N.G., Fomicheva M.V., Zubkov E.V., Sokol M.B., Gukasova N.V., Severin E.S.

Q3 Russian Chemical Bulletin, 2018, цитирований: 7

Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells

Sokol M.B., Nikolskaya E.D., Yabbarov N.G., Zenin V.A., Faustova M.R., Belov A.V., Zhunina O.A., Mollaev M.D., Zabolotsky A.I., Tereshchenko O.G., Severin E.S.

Q2 Journal of Biomedical Materials Research - Part B Applied Biomaterials, 2018, цитирований: 27

Яббаров Никита

Общих публикаций: 17

Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe

Yabbarov N., Nikolskaya E., Sokol M., Mollaeva M., Chirkina M., Seregina I., Gulyaev M., Pirogov Y., Petrov R.

Q1 International Journal of Molecular Sciences, 2022, цитирований: 0 ,

Open Access

Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles

Mollaeva M.R., Nikolskaya E., Beganovskaya V., Sokol M., Chirkina M., Obydennyi S., Belykh D., Startseva O., Mollaev M.D., Yabbarov N.

Q1 Antioxidants, 2021, цитирований: 3 ,

Open Access

Development of the Composition and Technology for Obtaining Paclitaxel Nanoscale Formulation Consisting of a Conjugate of Polymer Particles with a Protein Vector Molecule

Sokol M.B., Yabbarov N.G., Mollaeva M.R., Chirkina (Fomicheva) M.V., Balaban'yan V.Y., Nikolskaya E.D.

Q3 Drug development & registration, 2021, цитирований: 2

Optimization, Characterization and Pharmacokinetic Study of Meso-Tetraphenylporphyrin Metal Complex-Loaded PLGA Nanoparticles

Mollaeva M.R., Yabbarov N., Sokol M., Chirkina M., Mollaev M.D., Zabolotskii A., Seregina I., Bolshov M., Kaplun A., Nikolskaya E.

Q1 International Journal of Molecular Sciences, 2021, цитирований: 3 ,

Open Access

Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli

Mollaev M., Zabolotskii A., Gorokhovets N., Nikolskaya E., Sokol M., Tsedilin A., Mollaeva M., Chirkina M., Kuvaev T., Pshenichnikova A., Yabbarov N.

Q2 Journal of Genetic Engineering and Biotechnology, 2021, цитирований: 2 ,

Open Access

Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study

Sokol M., Zenin V., Yabbarov N., Mollaev M., Zabolotsky A., Mollaeva M., Fomicheva M., Kuznetsov S., Popenko V., Seregina I., Nikolskaya E.

Q3 Annales Pharmaceutiques Francaises, 2021, цитирований: 1

Obtaining and Purification of Recombinant Domain III of Human Alpha-Fetoprotein

Mollaev M.D., Zabolotskii A.I., Mazalev D.A., Gorokhovets N.V., Sokol M.B., Mollaeva M.R., Fomicheva M.V., Pshenichnikova A.B., Nikolskaya E.D.

Q4 Biotekhnologiya, 2021, цитирований: 2

Validation of a UV-Spectrophotometric Method for Quantitative Determination of Paclitaxel in a Targeted Delivery System Based on Poly(Lactic–Glycolic Acid) Copolymer Nanoparticles

Sokol M.B., Sycheva Y.V., Yabbarov N.G., Zabolotskii A.I., Mollaev M.D., Faustova M.R., Tereshchenko O.G., Fomicheva M.V., Nikol’skaya E.D.

Q4 Pharmaceutical Chemistry Journal, 2020, цитирований: 0

Metalloporphyrins in Medicine: From History to Recent Trends.

Faustova M., Nikolskaya E., Sokol M., Fomicheva M., Petrov R., Yabbarov N.

Q1 ACS Applied Bio Materials, 2020, цитирований: 7

Cellular internalization of targeted and non-targeted delivery systems for contrast agents based on polyamidoamine dendrimers

Sokol M.B., Faustova M.R., Nikolskaya E.D., Zhunina O.A., Fomicheva M.V., Petrov R.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2020, цитирований: 4

Polymer particles containing Fe-based metalloporphyrin as a highly efficient stimulator of reactive oxygen species formation in vitro and in vivo

Faustova M.R., Nikolskaya E.D., Mollaev M.D., Sokol M.B., Zabolotsky A.I., Zhunina O.A., Fomicheva M.V., Schvets V.I., Lobanov A.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2019, цитирований: 2

High-effective reactive oxygen species inducer based on Mn-tetraphenylporphyrin loaded PLGA nanoparticles in binary catalyst therapy

Faustova M., Nikolskaya E., Sokol M., Zabolotsky A., Mollaev M., Zhunina O., Fomicheva M., Lobanov A., Severin E., Yabbarov N.

Q1 Free Radical Biology and Medicine, 2019, цитирований: 7

Type of pH sensitive linker reveals different time-dependent intracellular localization, in vitro and in vivo efficiency in alpha-fetoprotein receptor targeted doxorubicin conjugate

Mollaev M., Gorokhovets N., Nikolskaya E., Faustova M., Zabolotsky A., Zhunina O., Sokol M., Zamulaeva I., Severin E., Yabbarov N.

Q1 International Journal of Pharmaceutics, 2019, цитирований: 13 ,

Open Access

Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells

Sokol M.B., Nikolskaya E.D., Yabbarov N.G., Zenin V.A., Faustova M.R., Belov A.V., Zhunina O.A., Mollaev M.D., Zabolotsky A.I., Tereshchenko O.G., Severin E.S.

Q2 Journal of Biomedical Materials Research - Part B Applied Biomaterials, 2018, цитирований: 27

Development of a polymer system for the delivery of daunorubicin to tumor cells to overcome drug resistance

Nikolskaya E.D., Faustova M.R., Mollaev M.D., Zhunina O.A., Sokol M.B., Yabbarov N.G., Gukasova N.V., Lobanov A.V., Shvets V.I., Severin E.S.

Q3 Russian Chemical Bulletin, 2018, цитирований: 4

Моллаева Мария

Общих публикаций: 16

Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe

Yabbarov N., Nikolskaya E., Sokol M., Mollaeva M., Chirkina M., Seregina I., Gulyaev M., Pirogov Y., Petrov R.

Q1 International Journal of Molecular Sciences, 2022, цитирований: 0 ,

Open Access

Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles

Mollaeva M.R., Nikolskaya E., Beganovskaya V., Sokol M., Chirkina M., Obydennyi S., Belykh D., Startseva O., Mollaev M.D., Yabbarov N.

Q1 Antioxidants, 2021, цитирований: 3 ,

Open Access

Development of the Composition and Technology for Obtaining Paclitaxel Nanoscale Formulation Consisting of a Conjugate of Polymer Particles with a Protein Vector Molecule

Sokol M.B., Yabbarov N.G., Mollaeva M.R., Chirkina (Fomicheva) M.V., Balaban'yan V.Y., Nikolskaya E.D.

Q3 Drug development & registration, 2021, цитирований: 2

Optimization, Characterization and Pharmacokinetic Study of Meso-Tetraphenylporphyrin Metal Complex-Loaded PLGA Nanoparticles

Mollaeva M.R., Yabbarov N., Sokol M., Chirkina M., Mollaev M.D., Zabolotskii A., Seregina I., Bolshov M., Kaplun A., Nikolskaya E.

Q1 International Journal of Molecular Sciences, 2021, цитирований: 3 ,

Open Access

Expression of acid cleavable Asp-Pro linked multimeric AFP peptide in E. coli

Mollaev M., Zabolotskii A., Gorokhovets N., Nikolskaya E., Sokol M., Tsedilin A., Mollaeva M., Chirkina M., Kuvaev T., Pshenichnikova A., Yabbarov N.

Q2 Journal of Genetic Engineering and Biotechnology, 2021, цитирований: 2 ,

Open Access

Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study

Sokol M., Zenin V., Yabbarov N., Mollaev M., Zabolotsky A., Mollaeva M., Fomicheva M., Kuznetsov S., Popenko V., Seregina I., Nikolskaya E.

Q3 Annales Pharmaceutiques Francaises, 2021, цитирований: 1

Obtaining and Purification of Recombinant Domain III of Human Alpha-Fetoprotein

Mollaev M.D., Zabolotskii A.I., Mazalev D.A., Gorokhovets N.V., Sokol M.B., Mollaeva M.R., Fomicheva M.V., Pshenichnikova A.B., Nikolskaya E.D.

Q4 Biotekhnologiya, 2021, цитирований: 2

Validation of a UV-Spectrophotometric Method for Quantitative Determination of Paclitaxel in a Targeted Delivery System Based on Poly(Lactic–Glycolic Acid) Copolymer Nanoparticles

Sokol M.B., Sycheva Y.V., Yabbarov N.G., Zabolotskii A.I., Mollaev M.D., Faustova M.R., Tereshchenko O.G., Fomicheva M.V., Nikol’skaya E.D.

Q4 Pharmaceutical Chemistry Journal, 2020, цитирований: 0

Metalloporphyrins in Medicine: From History to Recent Trends.

Faustova M., Nikolskaya E., Sokol M., Fomicheva M., Petrov R., Yabbarov N.

Q1 ACS Applied Bio Materials, 2020, цитирований: 7

Cellular internalization of targeted and non-targeted delivery systems for contrast agents based on polyamidoamine dendrimers

Sokol M.B., Faustova M.R., Nikolskaya E.D., Zhunina O.A., Fomicheva M.V., Petrov R.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2020, цитирований: 4

Polymer particles containing Fe-based metalloporphyrin as a highly efficient stimulator of reactive oxygen species formation in vitro and in vivo

Faustova M.R., Nikolskaya E.D., Mollaev M.D., Sokol M.B., Zabolotsky A.I., Zhunina O.A., Fomicheva M.V., Schvets V.I., Lobanov A.V., Yabbarov N.G.

Q3 Russian Chemical Bulletin, 2019, цитирований: 2

High-effective reactive oxygen species inducer based on Mn-tetraphenylporphyrin loaded PLGA nanoparticles in binary catalyst therapy

Faustova M., Nikolskaya E., Sokol M., Zabolotsky A., Mollaev M., Zhunina O., Fomicheva M., Lobanov A., Severin E., Yabbarov N.

Q1 Free Radical Biology and Medicine, 2019, цитирований: 7

Formulation of perspective hepatoprotector polymeric forms based on silybin and ursodeoxycholic acid

Tereshchenko O.G., Nikolskaya E.D., Zhunina O.A., Zavarzina V.V., Yabbarov N.G., Fomicheva M.V., Zubkov E.V., Sokol M.B., Gukasova N.V., Severin E.S.

Q3 Russian Chemical Bulletin, 2018, цитирований: 7

Erratum to: Antitumor activity of carboplatin in the composition of a copolymer of lactic and glycolic acids (Russian Chemical Bulletin, (2017), 66, 10, (1867-1872), 10.1007/s11172-017-1959-5)

Nikolskaya E.D., Zhunina O.A., Yabbarov N.G., Zenin V.A., Tereshchenko O.G., Fomicheva M.V., Sokol M.B., Lobanov A.V., Severin E.S.

Q3 Russian Chemical Bulletin, 2017, цитирований: 0 ,

Open Access

Antitumor activity of carboplatin in the composition of a copolymer of lactic and glycolic acids

Nikolskaya E.D., Zhunina O.A., Yabbarov N.G., Zenin V.A., Tereshchenko O.G., Fomicheva M.V., Sokol M.B., Lobanov A.V., Severin E.S.

Q3 Russian Chemical Bulletin, 2017, цитирований: 1

Чиркина Маргарита

Общих публикаций: 1

Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe

Yabbarov N., Nikolskaya E., Sokol M., Mollaeva M., Chirkina M., Seregina I., Gulyaev M., Pirogov Y., Petrov R.

Q1 International Journal of Molecular Sciences, 2022, цитирований: 0 ,

Open Access

Гуляев Михаил

Области научных интересов

Ядерный магнитный резонанс

Ученые продемонстрировали увеличение внутриопухолевого накопления и усиление противоопухолевого эффекта, используя стратегию двойного нацеливания

Стратегия одновременного двойного нацеливания на два разных участка опухолевой ткани может способствовать увеличению накопления лекарственных препаратов в раковых клетках как для терапевтических, так и для диагностических целей.

Дизайн лекарств

Молекулярная биология

Онкология

10 июля 2022